Miriam Johnson

Faculty and Department

  • Faculty of Health Sciences
  • Hull York Medical School

Recent outputs

View more outputs

Journal Article

Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study

Boland, J. W., Allgar, V., Boland, E. G., Kaasa, S., Hjermstad, M. J., & Johnson, M. J. (2019). Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study. Palliative medicine, 33(2), 206-212. https://doi.org/10.1177/0269216318811011

Low agreement between mMRC rated by patients and clinicians - implications for practice

Ekstrom, M., Chang, S., Johnson, M., Fazekas, B., Kochovska, S., Huang, C., & Currow, D. (2019). Low agreement between mMRC rated by patients and clinicians - implications for practice. The European respiratory journal, 54(6), https://doi.org/10.1183/13993003.01517-2019

Low-intensity educational interventions supporting self-management to improve outcomes related to chronic breathlessness: a systematic review

Raymond, B., Johnson, M., Luckett, T., Hutchinson, A., Lovell, M., & Phillips, J. (2019). Low-intensity educational interventions supporting self-management to improve outcomes related to chronic breathlessness: a systematic review. NPJ Primary Care Respiratory Medicine, 29, https://doi.org/10.1038/s41533-019-0152-8

Intention-to-treat analyses for randomised controlled trials in hospice/palliative care: the case for analyses to be of people exposed to the intervention.

Currow, D. C., Higginson, I. J., Portenoy, R. K., Hussain, J. A., Kochovska, S., Huang, C., …Currow, D. C. (2019). Intention-to-treat analyses for randomised controlled trials in hospice/palliative care: the case for analyses to be of people exposed to the intervention. Journal of pain and symptom management, https://doi.org/10.1016/j.jpainsymman.2019.10.026

Randomised, double-blind, multi-centre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B Feasibility)

Higginson, I., Wilcock, A., Johnson, M., Bajwah, S., Currow, D., Lovell, N., …Brown, S. (2020). Randomised, double-blind, multi-centre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B Feasibility). Thorax, https://doi.org/10.1136/thoraxjnl-2019-213879